AC
AXGN icon

Armistice Capital’s Axogen AXGN Stock Holding History

Armistice Capital’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8M Sell
775,000
-161,000
-17% -$6.49M 0.44% 35
2026
Q1 		$31M Hold
936,000
– – 0.55% 31
2025
Q4 		$30.6M Sell
936,000
-264,000
-22% -$6.49M 0.36% 47
2025
Q3 		$21.4M Buy
1,200,000
+88,681
+8% +$1.29M 0.32% 48
2025
Q2 		$12.1M Buy
1,111,319
+573,041
+106% +$7.51M 0.21% 62
2025
Q1 		$9.96M Sell
538,278
-74,722
-12% -$1.35M 0.15% 93
2024
Q4 		$10.1M Buy
613,000
+212,945
+53% +$3.02M 0.14% 95
2024
Q3 		$5.61M Buy
+400,055
New +$4.42M 0.09% 116

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Armistice Capital's AXGN Position: Q2 2026 in Review

Armistice Capital reduced its Axogen (AXGN) stake by 17% in Q2 2026, selling an estimated $6.49M and leaving 775,000 shares worth $35.8M. The position accounts for 0.44% of the portfolio, ranked #35.

Armistice Capital first reported a position in AXGN in Q3 2024 and has held it in 8 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Armistice Capital held 775,000 shares of Axogen worth $35.8M as of Q2 2026.
  • Armistice Capital sold 161,000 Axogen shares in Q2 2026, an estimated $6.49M.
  • Axogen made up 0.44% of Armistice Capital's portfolio in Q2 2026, its #35 holding.
  • Armistice Capital first reported a position in Axogen in Q3 2024 and has held it in 8 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.